ELEGEN
Elegen is a biotechnology company that develops microfluidic technology. It is driven by a mission to deploy this technology in a new generation of DNA synthesizers aimed at enabling and accelerating biomedical advances. The company was founded in 2017 and led by Dr. Matthew Hill.
ELEGEN
Industry:
Biotechnology Health Care Life Science
Founded:
2017-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.elegenbio.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Amazon Amazon Route 53
Similar Organizations
Cambridge Science
Cambridge Science is a biotechnology company that focuses on scientific-technological innovation.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Prestizia
Prestizia is a biotechnology company that is developing a microRNA1 technology.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sahsen Ventures
Sahsen Ventures investment in Seed Round - Elegen
Alix Ventures
Alix Ventures investment in Seed Round - Elegen
Official Site Inspections
http://www.elegenbio.com Semrush global rank: 8.67 M Semrush visits lastest month: 272
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Elegen"
Elegen - Crunchbase Company Profile & Funding
Elegen is a biotechnology company that develops microfluidic technology. ENFINIA DNA: A cell-free DNA synthesis technology producing long, complex, linear DNA up to 7kb in length with a 99.999% per base accuracy, shipped in …See details»
Elegen Team - ElegenBio
Meet the people who are powering bioeconomy with high-accuracy DNA synthesis.See details»
ELEGEN - LinkedIn
ELEGEN | 5,582 followers on LinkedIn. Unlock the promise of synthetic biology by accelerating the Design-Build-Test-Learn cycle | We are now at the dawn of the synthetic biology …See details»
Company - ElegenBio
Sign up to receive elegen news Subscribe to our latest news and product updates. (enter work email address only).See details»
Elegen Company Profile 2024: Valuation, Funding
Elegen General Information Description. Developer of microfluidics technology designed to disrupt synthetic biology. The company leverages technology for the engineering of entire genomes and the rapid development of DNA …See details»
Elegen - Overview, News & Similar companies | ZoomInfo.com
Www.elegenbio.com. Revenue $8 Million. Industry Education General Education . Recent News & Media. Fenwick Represents Elegen in $35M Series B Financing. May 15, 2024. …See details»
Elegen | The Healthcare Technology Report.
Elegen uses a proprietary microfluidics approach to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare, and pharma industries. Founded in 2017, …See details»
Elegen Corp. - VentureRadar
Website: https://www.elegenbio.com/ Provides DNA synthesis and production services, using a proprietary microfluidics approach, for industries such as agriculture ...See details»
ELEGEN Company Overview, Contact Details & Competitors | LeadIQ
May 14, 2024 Breakthrough Biotechnology Elegen is at the forefront of the synthetic biology revolution, developing ground-breaking DNA writing technologies to reprogram biology and …See details»
Press Release Service: Elegen Raises $35 Million in …
May 14, 2024 Founded in 2017, Elegen is privately held and based in the San Francisco Bay Area. For more information, visit elegenbio.com, find us on LinkedIn or follow us on Twitter @ElegenBio. Contacts. ELEGEN CONTACT. …See details»
Elegen Corp | Scientist.com
Elegenbio.com: Headquarters: San Carlos, CA, US Company Type: Small Business (1-10M TTM Revenue) Description Services Sites ... If your organization has a Scientist.com marketplace, …See details»
Elegen Raises $35 Million in Series B to Accelerate Expansion into ...
May 13, 2024 Elegen uses a proprietary microfluidics approach to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare and pharma industries. Founded …See details»
Elegen Corp. - VentureRadar
Similar Companies: NunaBio United Kingdom Privately Held Founded in April 2021 as a spin-out from Newcastle University, NunaBio is developing a novel method of DNA synthesis which …See details»
Synthetic Biology Is Set To Explode, But Only Once This Huge
Apr 24, 2023 “We produce full length DNA up to 7000 bases with 99.999% per base accuracy in seven business days,” he says. “Right now there's nothing on the market that comes even …See details»
News - ElegenBio
Elegen’s ENFINIA™ DNA has been named “DNA Synthesis Technology Of The Year” by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and …See details»
Elegen Launches ENFINIA™ DNA, Rapid Long DNA Synthesis to
Mar 21, 2023 ENFINIA DNA is available now and can be ordered online at elegenbio.com. About Elegen. Elegen is bringing unique insights and technical innovation to create high-quality …See details»
Elegen Announces Multi-year Collaboration and Licensing …
Jan 24, 2024 GSK has signed a collaboration & licensing agreement to leverage Elegen's cell-free DNA manufacturing technology in the development of GSK’s vaccines & medicines.See details»
Elegen Raises $35 Million in Series B to Accelerate Expansion into ...
May 14, 2024 Elegen announced a Series B financing of $35 million led by Triatomic Capital. Also joining the round are strategic investors GSK, which recently entered a collaboration and …See details»